Therapeutic targeting the loss of the Birt-Hogg-Dube suppresser gene

Research output: Contribution to journal › Article › peer-review

Authors

Colleges, School and Institutes

Details

Original languageUndefined/Unknown
JournalEJC Supplements
Publication statusPublished - 2010
Save citation Saved citations (0)

Copy the text from this field...

View graph of relations

DOI

By the same authors

Therapeutic targeting the loss of the birt-hogg-dube suppressor gene

Xiaohong Lu, Wenbin Wei, Anne Reiman, Zsuzsanna Nagy, Farida Latif & Eamonn Maher, 1 Jan 2011, In: Molecular Cancer Therapeutics. 10, 1, p. 80-9 10 p.

Research output: Contribution to journal › Article

Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN)

Xiaohong Lu, Laurence Seabra, Anne Reiman, Zsuzsanna Nagy & Eamonn Maher, 20 Feb 2014, In: Oncogene. 33, 8, p. 956-65 10 p.

Research output: Contribution to journal › Article › peer-review

Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma

Wenbin Wei, Farida Latif & Eamonn Maher, 2013, In: Clinical epigenetics. 5, 1, p. 16

Research output: Contribution to journal › Article › peer-review

Diagnostic Utility of IDH1/2 Mutations to Distinguish Dedifferentiated Chondrosarcoma from Undifferentiated Pleomorphic Sarcoma of Bone

Farida Latif, 25 May 2017, In: Human Pathology.

Research output: Contribution to journal › Article › peer-review